Host-pathogen genetic interactions underlie tuberculosis susceptibility in genetically diverse mice [preprint]
暂无分享,去创建一个
Dirk | T. A. Bell | Martin T. Ferris | R. Baker | Ginger D. Shaw | Andrew J. Olive | B. Mishra | C. Sassetti | K. Papavinasasundaram | Rachel K. Meade | P. Hock | S. Ehrt | S. W. Park | K. Murphy | Ha-Na Lee | Clare M. Smith | Michael C. Kiritsy | Megan K. Proulx | F. Villena | Michelle M. Bellerose | B. K. Hampton | Charlotte J. Reames | Boehm | J. Frederick | E. Jarukit | Long | L. Colton | Linnertz | Schnappinger | M. Ferris | Kenan C. Murphy | Sae Woong Park | Bibhuti B. Mishra | Richard E. Baker | Long | Ha-Na Lee | J. Frederick | Boehm | Dirk
[1] M. Gurcan,et al. CXCL1: A new diagnostic biomarker for human tuberculosis discovered using Diversity Outbred mice , 2021, PLoS pathogens.
[2] R. Baker,et al. Distinct Bacterial Pathways Influence the Efficacy of Antibiotics against Mycobacterium tuberculosis , 2020, mSystems.
[3] Tilen Kranjc,et al. RNA Interference Screening Identifies Novel Roles for RhoBTB1 and RhoBTB3 in Membrane Trafficking Events in Mammalian Cells , 2020, Cells.
[4] J. Vieira,et al. Mycobacterium tuberculosis associated with severe tuberculosis evades cytosolic surveillance systems and modulates IL-1β production , 2020, Nature Communications.
[5] Lisa E. Gralinski,et al. Complex Genetic Architecture Underlies Regulation of Influenza-A-Virus-Specific Antibody Responses in the Collaborative Cross , 2020, Cell reports.
[6] Lisa E. Gralinski,et al. Content and Performance of the MiniMUGA Genotyping Array: A New Tool To Improve Rigor and Reproducibility in Mouse Research , 2020, Genetics.
[7] P. Wyatt,et al. PE/PPE proteins mediate nutrient transport across the outer membrane of Mycobacterium tuberculosis , 2020, Science.
[8] Kimberly A. Thomas,et al. Immune correlates of tuberculosis disease and risk translate across species , 2020, Science Translational Medicine.
[9] Scott M. Williams,et al. Genetics and evolution of tuberculosis pathogenesis: New perspectives and approaches. , 2020, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.
[10] A. Sher,et al. Mouse transcriptome reveals potential signatures of protection and pathogenesis in human tuberculosis , 2020, Nature Immunology.
[11] T. A. Bell,et al. Functionally Overlapping Variants Control Tuberculosis Susceptibility in Collaborative Cross Mice , 2019, mBio.
[12] R. Baker,et al. Common Variants in the Glycerol Kinase Gene Reduce Tuberculosis Drug Efficacy , 2019, mBio.
[13] E. Chesler,et al. High-Diversity Mouse Populations for Complex Traits. , 2019, Trends in genetics : TIG.
[14] William R. Harcombe,et al. Genomewide Assessment of Mycobacterium tuberculosis Conditionally Essential Metabolic Pathways , 2019, mSystems.
[15] D. Lauffenburger,et al. IFN-γ-independent immune markers of Mycobacterium tuberculosis exposure , 2019, Nature Medicine.
[16] Martin T. Ferris,et al. The Collaborative Cross: A Systems Genetics Resource for Studying Host-Pathogen Interactions , 2019, Cell Host & Microbe.
[17] Leonard McMillan,et al. Whole Genome Sequencing and Progress Toward Full Inbreeding of the Mouse Collaborative Cross Population , 2019, G3: Genes, Genomes, Genetics.
[18] Elissa J. Chesler,et al. Testing Pleiotropy vs. Separate QTL in Multiparental Populations , 2019, G3: Genes, Genomes, Genetics.
[19] B. Yandell,et al. R/qtl2: Software for Mapping Quantitative Trait Loci with High-Dimensional Data and Multiparent Populations , 2018, Genetics.
[20] C. Sassetti,et al. Modeling Diversity: Do Homogeneous Laboratory Strains Limit Discovery? , 2018, Trends in microbiology.
[21] T. S. Wilkinson,et al. A GWAS on Helicobacter pylori strains points to genetic variants associated with gastric cancer risk , 2018, BMC Biology.
[22] A. Sher,et al. Lysosomal Cathepsin Release Is Required for NLRP3-Inflammasome Activation by Mycobacterium tuberculosis in Infected Macrophages , 2018, Front. Immunol..
[23] V. Mizrahi,et al. Mycobacterium tuberculosis. , 2018, Trends in microbiology.
[24] Michael Inouye,et al. Frequent transmission of the Mycobacterium tuberculosis Beijing lineage and positive selection for EsxW Beijing variant in Vietnam , 2018, Nature Genetics.
[25] B. Yandell,et al. Genetic Drivers of Pancreatic Islet Function , 2018, Genetics.
[26] C. Sassetti,et al. ORBIT: a New Paradigm for Genetic Engineering of Mycobacterial Chromosomes , 2018, mBio.
[27] Andrew J. Olive,et al. The Phagocyte Oxidase Controls Tolerance to Mycobacterium tuberculosis Infection , 2017, The Journal of Immunology.
[28] J. Fellay,et al. Genetics of human susceptibility to active and latent tuberculosis: present knowledge and future perspectives. , 2017, The Lancet. Infectious diseases.
[29] Anuj Srivastava,et al. Genomes of the Mouse Collaborative Cross , 2017, Genetics.
[30] Lisa E. Gralinski,et al. Allelic Variation in the Toll-Like Receptor Adaptor Protein Ticam2 Contributes to SARS-Coronavirus Pathogenesis in Mice , 2017, G3: Genes, Genomes, Genetics.
[31] M. Chase,et al. Digitally Barcoding Mycobacterium tuberculosis Reveals In Vivo Infection Dynamics in the Macaque Model of Tuberculosis , 2017, mBio.
[32] C. Spencer,et al. Genome-to-genome analysis highlights the impact of the human innate and adaptive immune systems on the hepatitis C virus , 2017 .
[33] Xinchun Chen,et al. Nitric oxide prevents a pathogen permissive granulocytic inflammation during tuberculosis , 2017, Nature Microbiology.
[34] T. Hawn,et al. MARCO variants are associated with phagocytosis, pulmonary tuberculosis susceptibility and Beijing lineage , 2016, Genes and Immunity.
[35] R. Baker,et al. Tuberculosis Susceptibility and Vaccine Protection Are Independently Controlled by Host Genotype , 2016, mBio.
[36] Daniel E. Zak,et al. A prospective blood RNA signature for tuberculosis disease risk , 2016, The Lancet.
[37] A. Sharpe,et al. CD4 T Cell-Derived IFN-γ Plays a Minimal Role in Control of Pulmonary Mycobacterium tuberculosis Infection and Must Be Actively Repressed by PD-1 to Prevent Lethal Disease , 2016, PLoS pathogens.
[38] Chia-Yu Kao,et al. The Mouse Universal Genotyping Array: From Substrains to Subspecies , 2015, G3: Genes, Genomes, Genetics.
[39] R. Brosch,et al. Revisiting the role of phospholipases C in virulence and the lifecycle of Mycobacterium tuberculosis , 2015, Scientific Reports.
[40] Thomas R. Ioerger,et al. TRANSIT - A Software Tool for Himar1 TnSeq Analysis , 2015, PLoS Comput. Biol..
[41] M. Gurcan,et al. Lung necrosis and neutrophils reflect common pathways of susceptibility to Mycobacterium tuberculosis in genetically diverse, immune-competent mice , 2015, Disease Models & Mechanisms.
[42] Whole genome? , 2015, Nature Genetics.
[43] R. Baker,et al. The Oxidative Stress Network of Mycobacterium tuberculosis Reveals Coordination between Radical Detoxification Systems. , 2015, Cell host & microbe.
[44] Kyle J. Minch,et al. A comprehensive map of genome-wide gene regulation in Mycobacterium tuberculosis , 2015, Scientific Data.
[45] Nathan D. Price,et al. The DNA-binding network of Mycobacterium tuberculosis , 2015, Nature Communications.
[46] J. Casanova,et al. Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-γ immunity. , 2014, Seminars in immunology.
[47] D. Soolingen,et al. Disclosure of Selective Advantages in the “modern” Sublineage of the Mycobacterium tuberculosis Beijing Genotype Family by Quantitative Proteomics , 2014 .
[48] R. Baker,et al. Genome-Wide Mutant Fitness Profiling Identifies Nutritional Requirements for Optimal Growth of Yersinia pestis in Deep Tissue , 2014, mBio.
[49] R. Brosch,et al. Evolutionary history of tuberculosis shaped by conserved mutations in the PhoPR virulence regulator , 2014, Proceedings of the National Academy of Sciences.
[50] D. van Soolingen,et al. Disclosure of Selective Advantages in the “modern” Sublineage of the Mycobacterium tuberculosis Beijing Genotype Family by Quantitative Proteomics* , 2014, Molecular & Cellular Proteomics.
[51] Thomas R. Ioerger,et al. Tryptophan Biosynthesis Protects Mycobacteria from CD4 T-Cell-Mediated Killing , 2013, Cell.
[52] M. Selman,et al. S100A8/A9 proteins mediate neutrophilic inflammation and lung pathology during tuberculosis. , 2013, American journal of respiratory and critical care medicine.
[53] Lisa E. Gralinski,et al. Modeling Host Genetic Regulation of Influenza Pathogenesis in the Collaborative Cross , 2013, PLoS pathogens.
[54] Hardy Kornfeld,et al. Nitric oxide controls the immunopathology of tuberculosis by inhibiting NLRP3 inflammasome–dependent processing of IL-1β , 2012, Nature Immunology.
[55] J. Casanova,et al. Mycobacterial Disease and Impaired IFN-γ Immunity in Humans with Inherited ISG15 Deficiency , 2012, Science.
[56] Steven C. Munger,et al. The diversity outbred mouse population , 2012, Mammalian Genome.
[57] B. Yandell,et al. Quantile-Based Permutation Thresholds for Quantitative Trait Loci Hotspots , 2012, Genetics.
[58] J. Ayres,et al. Tolerance of infections. , 2012, Annual review of immunology.
[59] R. Gopal,et al. IL‐23‐dependent IL‐17 drives Th1‐cell responses following Mycobacterium bovis BCG vaccination , 2012, European journal of immunology.
[60] Leonard McMillan,et al. High-Resolution Genetic Mapping Using the Mouse Diversity Outbred Population , 2012, Genetics.
[61] Thomas M. Keane,et al. Mouse genomic variation and its effect on phenotypes and gene regulation , 2011, Nature.
[62] D. Schnappinger,et al. Evaluating the Sensitivity of Mycobacterium tuberculosis to Biotin Deprivation Using Regulated Gene Expression , 2011, PLoS pathogens.
[63] A. Nebel,et al. Polymorphisms in MC3R promoter and CTSZ 3′UTR are associated with tuberculosis susceptibility , 2011, European Journal of Human Genetics.
[64] Ivana V. Yang,et al. Genetic analysis of complex traits in the emerging Collaborative Cross. , 2011, Genome research.
[65] A. Sher,et al. CD4 T Cells Promote Rather than Control Tuberculosis in the Absence of PD-1–Mediated Inhibition , 2011, The Journal of Immunology.
[66] D. Schnappinger,et al. Simultaneous Analysis of Multiple Mycobacterium tuberculosis Knockdown Mutants In Vitro and In Vivo , 2010, PloS one.
[67] Thomas Dick,et al. Vitamin B6 biosynthesis is essential for survival and virulence of Mycobacterium tuberculosis , 2010, Molecular microbiology.
[68] K. Kuhen,et al. A chemical genetic screen in Mycobacterium tuberculosis identifies carbon-source-dependent growth inhibitors devoid of in vivo efficacy , 2010, Nature Communications.
[69] S. Almo,et al. Programmed death-1 (PD-1)–deficient mice are extraordinarily sensitive to tuberculosis , 2010, Proceedings of the National Academy of Sciences.
[70] I. Smith,et al. The Mycobacterium tuberculosis High-Affinity Iron Importer, IrtA, Contains an FAD-Binding Domain , 2009, Journal of bacteriology.
[71] Steve Horvath,et al. WGCNA: an R package for weighted correlation network analysis , 2008, BMC Bioinformatics.
[72] Stefan Niemann,et al. High Functional Diversity in Mycobacterium tuberculosis Driven by Genetic Drift and Human Demography , 2008, PLoS biology.
[73] J. Kos,et al. Maturation of dendritic cells depends on proteolytic cleavage by cathepsin X , 2008, Journal of leukocyte biology.
[74] Falk Hildebrand,et al. Origin, Spread and Demography of the Mycobacterium tuberculosis Complex , 2008, PLoS pathogens.
[75] G. Sirugo,et al. Mapping of a novel susceptibility locus suggests a role for MC3R and CTSZ in human tuberculosis. , 2008, American journal of respiratory and critical care medicine.
[76] Christopher M. Sassetti,et al. Mycobacterial persistence requires the utilization of host cholesterol , 2008, Proceedings of the National Academy of Sciences.
[77] J. Farrar,et al. The Influence of Host and Bacterial Genotype on the Development of Disseminated Disease with Mycobacterium tuberculosis , 2008, PLoS pathogens.
[78] R. Locksley,et al. IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge , 2007, Nature Immunology.
[79] C. Bodemer,et al. X-linked susceptibility to mycobacteria is caused by mutations in NEMO impairing CD40-dependent IL-12 production , 2006, The Journal of experimental medicine.
[80] Stefan Niemann,et al. Variable host-pathogen compatibility in Mycobacterium tuberculosis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[81] P. Tucker,et al. A novel two‐component system found in Mycobacterium tuberculosis , 2005, FEBS letters.
[82] E. Muñoz-Elías,et al. Replication Dynamics of Mycobacterium tuberculosis in Chronically Infected Mice , 2005, Infection and Immunity.
[83] Nengjun Yi,et al. The Collaborative Cross, a community resource for the genetic analysis of complex traits , 2004, Nature Genetics.
[84] R. Fleischmann,et al. Attenuation of Late-Stage Disease in Mice Infected bythe Mycobacterium tuberculosis Mutant Lacking theSigF Alternate Sigma Factor and Identification ofSigF-Dependent Genes by MicroarrayAnalysis , 2004, Infection and Immunity.
[85] Christopher M. Sassetti,et al. Genetic requirements for mycobacterial survival during infection , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[86] S. Raghavan,et al. Acute infection and macrophage subversion by Mycobacterium tuberculosis require a specialized secretion system , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[87] E. Rubin,et al. Genes required for mycobacterial growth defined by high density mutagenesis , 2003, Molecular microbiology.
[88] I. Orme,et al. CD4 is required for the development of a protective granulomatous response to pulmonary tuberculosis. , 2002, Cellular immunology.
[89] V. Deretic,et al. Silencing of Oxidative Stress Response in Mycobacterium tuberculosis: Expression Patterns of ahpC in Virulent and Avirulent Strains and Effect ofahpC Inactivation , 2001, Infection and Immunity.
[90] P. Ortiz de Montellano,et al. The AhpC and AhpD Antioxidant Defense System of Mycobacterium tuberculosis * , 2000, The Journal of Biological Chemistry.
[91] J. Flynn,et al. Mice deficient in CD4 T cells have only transiently diminished levels of IFN-gamma, yet succumb to tuberculosis. , 1999, Journal of immunology.
[92] F. Deist,et al. Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. , 1998, Science.
[93] Lei Chen,et al. Alkyl hydroperoxide reductase subunit C (AhpC) protects bacterial and human cells against reactive nitrogen intermediates. , 1998, Molecular cell.
[94] I. Orme,et al. Interleukin 12 (IL-12) Is Crucial to the Development of Protective Immunity in Mice Intravenously Infected with Mycobacterium tuberculosis , 1997, The Journal of experimental medicine.
[95] R. Doerge,et al. Empirical threshold values for quantitative trait mapping. , 1994, Genetics.
[96] J. Flynn,et al. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection , 1993, The Journal of experimental medicine.
[97] I. Orme,et al. Disseminated tuberculosis in interferon gamma gene-disrupted mice , 1993, The Journal of experimental medicine.
[98] R. Lumb,et al. Mycobacterium bovis (BCG) vaccination , 1992, Medical Journal of Australia.
[99] Acute Infection , 2020, Encyclopedia of Behavioral Medicine.
[100] R. Baker,et al. Identifying essential genes in Mycobacterium tuberculosis by global phenotypic profiling. , 2015, Methods in molecular biology.
[101] L. Goitre,et al. The Ras superfamily of small GTPases: the unlocked secrets. , 2014, Methods in molecular biology.
[102] W. Bishai,et al. Sigma factors of Mycobacterium tuberculosis. , 1997, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[103] R. Bitsch. Vitamin B6. , 1993, International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition.
[104] G. Comstock. Tuberculosis in twins: a re-analysis of the Prophit survey. , 1978, The American review of respiratory disease.
[105] G. C.. Genetics and Evolution , 1918, Nature.
[106] Howard C. Berg,et al. Genetic analysis , 1957, Nature Biotechnology.